News Focus
News Focus
icon url

jq1234

11/18/10 4:16 PM

#109216 RE: DewDiligence #109214

It's not semantic. Look at Denosumab study endpoint in HRPC, it is time to skeletal-related events (SREs). EXEL184 won't be tested this way, it is for cancer treatment, with OS endpoint likely. They are not comparable.